Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa
Preprint
Abstract
Background Children discharged from hospital after recovery from severe malarial anaemia (SMA) are at high risk of readmission and death in subsequent months. Clinical trial results show that three months of post-discharge malaria chemoprevention (PMC) with dihydroartemisinin-piperaquine reduces this risk. Methods We developed a compartmental mathematical model describing the daily post-discharge incidence of uncomplicated and severe malaria requiring readmission among a cohort of 0-5 year-old children. We fitted the model to PMC and placebo groups from nine trial hospitals in areas of moderate-to-intense malaria transmission in Uganda and Kenya using Bayesian methods. The cohort model was then embedded within a full population model of SMA to predict impact of PMC across malaria-endemic African countries. Findings The incidence of hospitalised malaria episodes during the first 6 months post-discharge is estimated to be ∼23-60 times higher than the average for children of this age, depending on transmission intensity. We estimate that repeat SMA episodes within 6 months of the original episode constitute 18-27% of all SMA episodes in high transmission settings. In the 20 highest-burden countries in Africa, only 2-5 children need to be given PMC to prevent one hospitalised malaria episode, and less than 100 to prevent one death. If all hospitalised cases access PMC, we estimate that 36,000 (range 16,000-82,000) malaria-associated readmissions could be prevented annually, depending on the proportion accessing hospital care. Interpretation PMC has high potential impact per child treated across a range of epidemiological settings in Africa. Funding Research Council of NorwayKeywords
All Related Versions
- Published version: Nature Communications, 14 (1), 1.
This publication has 32 references indexed in Scilit:
- Defining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malariaNature Communications, 2015
- Incidence of catastrophic health expenditures for households: An example of medical attention for the treatment of severe childhood malaria in Kinshasa reference hospitals, Democratic Republic of CongoJournal of Infection and Public Health, 2015
- Gradual acquisition of immunity to severe malaria with increasing exposureProceedings Of The Royal Society B-Biological Sciences, 2015
- Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysisNature Communications, 2014
- Severe MalariaTropical Medicine & International Health, 2014
- Intermittent preventive therapy for malaria with monthly artemether–lumefantrine for the post-discharge management of severe anaemia in children aged 4–59 months in southern Malawi: a multicentre, randomised, placebo-controlled trialThe Lancet Infectious Diseases, 2012
- Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention StrategiesPLOS Medicine, 2010
- Long Term Outcome of Severe Anaemia in Malawian ChildrenPLOS ONE, 2008
- Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivoBlood, 2006
- Inference from Iterative Simulation Using Multiple SequencesStatistical Science, 1992